在家治疗心力衰竭:非随机前性病例对照试验 (HeMan at Home)
Justin Helberg1, Daniel Bensimhon2, Vasili Katsadouros3
1Internal Medicine Teaching Service, Cone Health, Greensboro, North Carolina, USA Justin.t.helberg@gmail.com.
Open heart
|December 8, 2023
概括
家庭医院 (HAH) 是急性或慢性心力衰竭 (CHF) 患者的安全有效替代方案. 与传统住院治疗相比,这项试点计划显示不良事件较少,患者满意度增加.
科学领域:
- 心脏病学 心脏病学
- 医疗保健管理的管理
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一个显著且日益增长的临床和经济挑战.
- COVID-19大流行加剧了高风患者护理问题,导致发病率和死亡率增加.
- 评估像在家医院 (HAH) 等替代护理模式对于管理急性至慢性HF (CHF) 至关重要.
研究的目的:
- 评估家庭医院 (HAH) 模型对急性或慢性心力衰竭 (CHF) 患者的质量和安全性.
- 为了比较HAH与通常的医院护理 (UC) 关于患者的结果和满意度.
- 为了确定HAH的可行性,作为传统住院治疗的替代方案.
主要方法:
- 一项前性,非随机的病例对照研究,比较HAH和常规护理 (UC) 对CHF患者.
- 主要结局包括停留时间 (LOS),不良事件,出院倾向和患者满意度.
- 二次结果评估了30天的再入院率,急诊室 (ED) 使用率和ED停留时间.
主要成果:
- 与UC患者相比,HAH患者的不良事件较少 (12.5%与35%) 和患者满意度更高.
- 停留时间在HAH中略长 (6.3天而不是4.7天),但再入院和ED使用率相似.
- 在HAH计划中的患者在出院后不太可能需要急性后服务.
结论:
- 家庭医院 (HAH) 试点项目被证明是为选择的慢性心力衰竭患者提供安全有效的护理选择.
- 在不增加再入院的情况下,HAH提供了一种可行的选择,以减少不良事件并提高患者满意度.
- 该模型展示了在心力衰竭管理中优化护理提供和资源利用的潜力.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:17Imaging Studies for Cardiovascular System I:Echocardiography
336
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
336
01:22Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
01:26Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594